RIVENDELL GROUP LLP for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HCR -Issues related to healthcare legislation, drug pricing generally including and the 340B Drug Discount Program; issues and policies relating to the FDA including biopharmaceutical development and biosimilars; general education about policies impacting pharmaceutical development, approval, reimbursement and pricing; issues related to health equity, diversity, and inclusion in clinical trials; issues related to public health preparedness and response.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Medicare/Medicaid MMM
Issues related to Medicare and Medicaid coverage and reimbursement; 340B Drug Discount Program; drug pricing generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.